Monitor platelet counts for patients w/ preexisting myelosuppression (including anemia, leucopenia, pancytopenia & thrombocytopenia), increased risk of bleeding, receiving concomitant medications that may decrease platelet count of linezolid for >2 wk. Visual function should be monitored (extended period). Lactic acidosis, serotonin syndrome. Pregnancy & lactation.